The positive opinion for use of Cosentyx either alone or in combination with methotrexate has been given for the juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) The post Novartis’ Cosentyx gets CHMP positive opinion for use in childhood arthritic conditions appeared first on Pharmaceutical Business review. … [Read more...]

Proceeds from the financing round will be used by the company to advance Inceptor Bio’s CAR-T lead programme to a Phase I clinical trial as well as continue The post Inceptor Bio raises $37m from Series A to advance CAR-T lead programme appeared first on Pharmaceutical Business review. … [Read more...]

Anthracyclines just as doxorubicin are the initial treatment of choice for TNBC. Although doxorubicin has reduced breast cancer mortality significantly, it is linked with a dose-dependent cumulative and The post NovoMedix gets NIH grant to advance NMX1 in TNBC appeared first on Pharmaceutical Business review. … [Read more...]

Grupo Somar is an integrated pharmaceutical company with focus on developing, manufacturing, and marketing branded generic, private label and OTC products aimed at the private market and providing The post Procaps Group signs agreement to buy Grupo Somar appeared first on Pharmaceutical Business review. … [Read more...]

This round was led by founding investors Syncona and Mass General Brigham Ventures. With this new funding round, SwanBio has so far raised $133m. SwanBio chair and chief The post SwanBio raises $56m to advance new gene therapies for neurological conditions appeared first on Pharmaceutical Business review. … [Read more...]